On July 2, 2018 Verastem, Inc. (NASDAQ:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, reported that the Company will participate in the Oppenheimer Boston Oncology Insight Summit on July 10-11, 2018, in Boston, Massachusetts (Press release, Verastem, JUL 2, 2018, View Source;p=RssLanding&cat=news&id=2356739 [SID1234527540]). The two-day event will feature oncology-focused companies and will consist of one-on-one meetings with institutional investors preceded by a Lecture Series from members of the Whitehead Institute in Cambridge, Massachusetts.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Members of Verastem Oncology’s executive team will participate in the event. To learn more about the event please visit the following link: View Source